Surya Pharma at lifetime high on robust Q1 results

BSE 23 May 12 | 12:00 AM

3.81		-0.19 (-4.75%)
Mkt Price (Rs)		Chg Rs (Chg %)

Code: 532516

Face Value: N.A.

NSE 23 May 12 | 12:00 AM

3.80		-0.2 (-5%)
Mkt Price (Rs)		Chg Rs (Chg %)

Code: SURYAPHARM

Performance
1 Week	:	Rs	4.31	(-11.60%)
1 Month	:	Rs	7.75	(-50.84%)
1 Year	:	Rs	20.10	(-81.04%)

Surya Pharma at lifetime high on robust Q1 results

SI Reporter / Mumbai 16 Aug 10 | 02:11 PM

Be the first to comment

Surya Pharma is trading at a lifetime high, up 10% at Rs 205 after the company posted a 74% jump in net profit to Rs 23.34 crore for the quarter ended June 2010 against Rs 13.37 crore during the same quarter of the previous year.

The company posted higher net profit growth on the back of a 72% rise in net sales to Rs 358 crore (Rs 208 crore) on a y-o-y basis during the recently concluded quarter.

“During the quarter under review, the company commissioned one of its plants at its greenfield project at Jammu, while Surya Healthcare, the company’s subsidiary has set up 52 pharmacy retail stores under the brand name “VIVA&", the company said in its filing to the exchanges.

The stock of Surya Pharma opened at Rs 195 and touched a high of Rs 211 on the BSE. As many as 727,000 shares have changed hands on the counter till noon trades as against an average 17,000 shares traded daily in the past two weeks.